WHO ICTRP trial
MUC-1 targeted Chimeric Antigen Receptor T Cells (CART) Therapy in Breast Cancer
ChiCTR1900027907 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900027907 |
|---|---|
| Public title | MUC-1 targeted Chimeric Antigen Receptor T Cells (CART) Therapy in Breast Cancer |
| Scientific title | MUC-1 targeted Chimeric Antigen Receptor T Cells (CART) Therapy in Breast Cancer |
| Primary sponsor | The Fifth Hospital Affiliated to Zhongshan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Breast Cancer |
| Interventions | Case series:CART cells |
| Registration date | Dec 3, 2019 |
| Target size | Case series:6 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: